Who tf is CGN trial
CGN
ATN
| R | ACS | K | D | A | +/– | KAST | ADR | HS% | FK | FD | +/– | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.17 1.32 0.25 | 230 253 90 | 11 10 1 | / 13 10 3 / | 1 1 0 | -2 0 -2 | 50% 50% 50% | 149 166 48 | 27% 31% 0% | 0 0 0 | 0 0 0 | 0 0 0 | |
|
0.77 0.63 1.56 | 176 134 426 | 8 5 3 | / 13 11 2 / | 1 1 0 | -5 -6 +1 | 50% 42% 100% | 119 101 229 | 40% 40% 40% | 0 0 0 | 0 0 0 | 0 0 0 | |
|
Zyppan
CGN
|
|
0.49 0.61 0.01 | 127 149 -3 | 4 5 -1 | / 13 11 2 / | 5 5 0 | -9 -6 -3 | 36% 42% | 87 101 | 28% 28% | 1 1 0 | 2 1 1 | -1 0 -1 |
|
Samed
CGN
|
|
0.42 0.48 0.04 | 150 168 44 | 6 6 0 | / 13 11 2 / | 2 1 1 | -7 -5 -2 | 50% 50% 50% | 97 106 45 | 30% 35% 0% | 3 3 0 | 4 4 0 | -1 -1 0 |
|
KovaQ
CGN
|
|
0.13 0.14 0.07 | 92 84 139 | 4 3 1 | / 13 11 2 / | 1 1 0 | -9 -8 -1 | 36% 33% 50% | 68 66 81 | 40% 43% 33% | 0 0 0 | 4 3 1 | -4 -3 -1 |
| R | ACS | K | D | A | +/– | KAST | ADR | HS% | FK | FD | +/– | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.82 0.90 1.98 | 356 210 380 | 20 2 18 | / 7 2 5 / | 4 1 3 | +13 0 +13 | 86% 100% 83% | 224 120 241 | 65% 67% 64% | 2 0 2 | 0 0 0 | +2 0 +2 | |
|
1.37 3.39 1.03 | 222 482 179 | 12 4 8 | / 6 0 6 / | 2 1 1 | +6 +4 +2 | 86% 100% 83% | 144 260 125 | 47% 67% 38% | 2 0 2 | 1 0 1 | +1 0 +1 | |
|
1.33 1.68 1.27 | 274 275 274 | 14 2 12 | / 8 1 7 / | 2 0 2 | +6 +1 +5 | 86% 100% 83% | 172 143 176 | 56% 14% 72% | 4 2 2 | 0 0 0 | +4 +2 +2 | |
|
1.32 1.62 1.27 | 202 254 193 | 10 2 8 | / 6 1 5 / | 4 1 3 | +4 +1 +3 | 86% 100% 83% | 147 258 129 | 10% 40% 0% | 2 0 2 | 3 0 3 | -1 0 -1 | |
|
0.98 0.81 1.01 | 150 66 164 | 8 0 8 | / 6 1 5 / | 5 3 2 | +2 -1 +3 | 79% 100% 75% | 105 54 114 | 35% 0% 42% | 0 0 0 | 0 0 0 | 0 0 0 |
| R | ACS | K | D | A | +/– | KAST | ADR | HS% | FK | FD | +/– | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KovaQ
CGN
|
|
2.04 2.31 2.24 | 469 368 503 | 28 6 22 | / 7 2 5 / | 2 1 1 | +21 +4 +17 | 88% 75% 92% | 268 185 296 | 28% 40% 26% | 8 0 8 | 0 0 0 | +8 0 +8 |
|
Zyppan
CGN
|
|
1.57 1.45 1.48 | 283 341 264 | 17 5 12 | / 8 3 5 / | 5 2 3 | +9 +2 +7 | 81% 75% 83% | 192 218 183 | 29% 33% 28% | 1 0 1 | 2 2 0 | -1 -2 +1 |
|
1.30 1.66 1.47 | 259 249 302 | 55 25 30 | / 37 22 15 / | 28 17 11 | +18 +3 +15 | 77% 68% 86% | 179 164 195 | 17% 21% 14% | 4 2 2 | 0 0 0 | +4 +2 +2 | |
|
KovaQ
CGN
|
|
1.21 1.00 1.11 | 232 252 212 | 26 15 11 | / 24 12 12 / | 5 3 2 | +2 +3 -1 | 63% 60% 67% | 155 164 145 | 50% 46% 55% | 4 1 3 | 4 3 1 | 0 -2 +2 |
|
0.83 1.26 1.04 | 187 178 218 | 38 16 22 | / 43 27 16 / | 22 14 8 | -5 -11 +6 | 73% 58% 90% | 128 123 133 | 26% 23% 29% | 5 2 3 | 4 2 2 | +1 0 +1 | |
|
Samed
CGN
|
|
1.24 0.83 0.93 | 189 194 187 | 12 4 8 | / 10 2 8 / | 3 0 3 | +2 +2 0 | 75% 50% 83% | 125 153 116 | 21% 50% 10% | 1 0 1 | 1 1 0 | 0 -1 +1 |
|
Zyppan
CGN
|
|
1.28 0.56 0.92 | 174 248 100 | 16 13 3 | / 21 11 10 / | 10 3 7 | -5 +2 -7 | 73% 80% 67% | 126 164 89 | 24% 30% 14% | 1 1 0 | 3 1 2 | -2 0 -2 |
|
Samed
CGN
|
|
0.45 1.09 0.77 | 203 160 246 | 21 7 14 | / 27 14 13 / | 6 3 3 | -6 -7 +1 | 63% 67% 60% | 135 110 160 | 33% 26% 38% | 3 2 1 | 5 2 3 | -2 0 -2 |
|
Zyppan
CGN
|
|
0.61 0.01 0.49 | 127 149 -3 | 4 5 -1 | / 13 11 2 / | 5 5 0 | -9 -6 -3 | 36% 42% | 87 101 | 28% 28% | 1 1 0 | 2 1 1 | -1 0 -1 |
|
Samed
CGN
|
|
0.48 0.04 0.42 | 150 168 44 | 6 6 0 | / 13 11 2 / | 2 1 1 | -7 -5 -2 | 50% 50% 50% | 97 106 45 | 30% 35% 0% | 3 3 0 | 4 4 0 | -1 -1 0 |
|
KovaQ
CGN
|
|
0.14 0.07 0.13 | 92 84 139 | 4 3 1 | / 13 11 2 / | 1 1 0 | -9 -8 -1 | 36% 33% 50% | 68 66 81 | 40% 43% 33% | 0 0 0 | 4 3 1 | -4 -3 -1 |
| R | ACS | K | D | A | +/– | KAST | ADR | HS% | FK | FD | +/– | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.88 1.43 1.16 | 209 197 244 | 49 20 29 | / 40 24 16 / | 14 8 6 | +9 -4 +13 | 77% 72% 81% | 152 132 171 | 29% 32% 27% | 5 1 4 | 10 6 4 | -5 -5 0 | |
|
1.55 0.64 1.08 | 203 292 137 | 45 30 15 | / 42 20 22 / | 18 12 6 | +3 +10 -7 | 75% 72% 77% | 138 182 98 | 36% 43% 25% | 5 3 2 | 4 1 3 | +1 +2 -1 | |
|
0.67 1.24 0.97 | 227 140 272 | 47 16 31 | / 46 24 22 / | 15 7 8 | +1 -8 +9 | 65% 59% 71% | 135 97 170 | 58% 62% 56% | 6 1 5 | 2 1 1 | +4 0 +4 | |
|
0.34 1.21 0.79 | 229 168 288 | 45 14 31 | / 54 30 24 / | 12 6 6 | -9 -16 +7 | 77% 69% 84% | 143 106 178 | 39% 33% 43% | 11 4 7 | 11 8 3 | 0 -4 +4 | |
|
0.39 0.87 0.64 | 142 103 187 | 29 9 20 | / 46 25 21 / | 16 10 6 | -17 -16 -1 | 65% 59% 71% | 98 70 125 | 29% 18% 37% | 2 1 1 | 4 3 1 | -2 -2 0 |
CGN
ATN
CGN
ATN
| R | ACS | K | D | A | +/– | KAST | ADR | HS% | FK | FD | +/– | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.65 1.25 2.06 | 322 252 392 | 32 12 20 | / 18 10 8 / | 16 12 4 | +14 +2 +12 | 80% 73% 87% | 210 165 256 | 21% 17% 24% | 2 1 1 | 0 0 0 | +2 +1 +1 | |
|
1.18 1.04 1.31 | 229 210 248 | 21 9 12 | / 21 12 9 / | 13 10 3 | 0 -3 +3 | 73% 60% 87% | 148 141 154 | 27% 23% 32% | 5 2 3 | 3 2 1 | +2 0 +2 | |
|
KovaQ
CGN
|
|
1.11 1.21 1.00 | 232 252 212 | 26 15 11 | / 24 12 12 / | 5 3 2 | +2 +3 -1 | 63% 60% 67% | 155 164 145 | 50% 46% 55% | 4 1 3 | 4 3 1 | 0 -2 +2 |
|
Zyppan
CGN
|
|
0.92 1.28 0.56 | 174 248 100 | 16 13 3 | / 21 11 10 / | 10 3 7 | -5 +2 -7 | 73% 80% 67% | 126 164 89 | 24% 30% 14% | 1 1 0 | 3 1 2 | -2 0 -2 |
|
Samed
CGN
|
|
0.77 0.45 1.09 | 203 160 246 | 21 7 14 | / 27 14 13 / | 6 3 3 | -6 -7 +1 | 63% 67% 60% | 135 110 160 | 33% 26% 38% | 3 2 1 | 5 2 3 | -2 0 -2 |
| R | ACS | K | D | A | +/– | KAST | ADR | HS% | FK | FD | +/– | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.43 1.19 1.68 | 259 231 287 | 29 12 17 | / 17 10 7 / | 10 7 3 | +12 +2 +10 | 80% 80% 80% | 171 141 200 | 36% 34% 37% | 3 1 2 | 3 2 1 | 0 -1 +1 | |
|
1.16 1.84 0.48 | 244 371 117 | 26 20 6 | / 22 10 12 / | 9 5 4 | +4 +10 -6 | 80% 87% 73% | 157 227 88 | 33% 44% 15% | 3 3 0 | 2 0 2 | +1 +3 -2 | |
|
0.68 0.69 0.67 | 165 139 191 | 18 8 10 | / 24 11 13 / | 7 5 2 | -6 -3 -3 | 67% 73% 60% | 105 98 112 | 50% 62% 43% | 3 1 2 | 1 0 1 | +2 +1 +1 | |
|
0.67 0.11 1.23 | 240 162 318 | 23 7 16 | / 29 16 13 / | 6 3 3 | -6 -9 +3 | 77% 67% 87% | 147 108 186 | 34% 47% 29% | 5 2 3 | 7 4 3 | -2 -2 0 | |
|
0.60 0.32 0.89 | 163 108 218 | 15 5 10 | / 25 13 12 / | 9 6 3 | -10 -8 -2 | 67% 60% 73% | 108 78 138 | 22% 12% 32% | 1 0 1 | 2 2 0 | -1 -2 +1 |
CGN
ATN
| R | ACS | K | D | A | +/– | KAST | ADR | HS% | FK | FD | +/– | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KovaQ
CGN
|
|
2.24 2.04 2.31 | 469 368 503 | 28 6 22 | / 7 2 5 / | 2 1 1 | +21 +4 +17 | 88% 75% 92% | 268 185 296 | 28% 40% 26% | 8 0 8 | 0 0 0 | +8 0 +8 |
|
Zyppan
CGN
|
|
1.48 1.57 1.45 | 283 341 264 | 17 5 12 | / 8 3 5 / | 5 2 3 | +9 +2 +7 | 81% 75% 83% | 192 218 183 | 29% 33% 28% | 1 0 1 | 2 2 0 | -1 -2 +1 |
|
1.40 1.38 1.41 | 225 225 225 | 12 3 9 | / 6 2 4 / | 11 4 7 | +6 +1 +5 | 94% 100% 92% | 148 160 144 | 6% 15% 4% | 2 1 1 | 0 0 0 | +2 +1 +1 | |
|
1.00 0.61 1.13 | 156 185 146 | 9 2 7 | / 9 4 5 / | 8 3 5 | 0 -2 +2 | 94% 100% 92% | 98 119 92 | 14% 7% 19% | 0 0 0 | 1 0 1 | -1 0 -1 | |
|
Samed
CGN
|
|
0.93 1.24 0.83 | 189 194 187 | 12 4 8 | / 10 2 8 / | 3 0 3 | +2 +2 0 | 75% 50% 83% | 125 153 116 | 21% 50% 10% | 1 0 1 | 1 1 0 | 0 -1 +1 |
| R | ACS | K | D | A | +/– | KAST | ADR | HS% | FK | FD | +/– | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.75 0.60 1.18 | 160 129 253 | 9 6 3 | / 15 11 4 / | 4 1 3 | -6 -5 -1 | 44% 33% 75% | 112 92 174 | 63% 60% 67% | 1 0 1 | 1 1 0 | 0 -1 +1 | |
|
0.69 0.89 0.09 | 143 162 85 | 7 6 1 | / 14 10 4 / | 7 6 1 | -7 -4 -3 | 56% 50% 75% | 98 112 53 | 29% 32% 20% | 0 0 0 | 1 1 0 | -1 -1 0 | |
|
0.54 0.41 0.93 | 172 157 218 | 8 5 3 | / 17 13 4 / | 4 3 1 | -9 -8 -1 | 69% 67% 75% | 111 97 152 | 33% 25% 60% | 2 0 2 | 4 4 0 | -2 -4 +2 | |
|
0.51 0.36 0.95 | 167 144 235 | 10 6 4 | / 17 13 4 / | 0 0 0 | -7 -7 0 | 63% 58% 75% | 123 101 189 | 26% 25% 27% | 0 0 0 | 4 4 0 | -4 -4 0 | |
|
0.42 0.42 0.42 | 112 103 138 | 6 4 2 | / 15 11 4 / | 2 1 1 | -9 -7 -2 | 50% 50% 50% | 73 62 108 | 43% 44% 40% | 1 1 0 | 2 1 1 | -1 0 -1 |